查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888702

黴漿菌檢測市場規模、佔有率和趨勢分析（按產品、技術、應用、最終用途、地區和細分市場預測，2025-2033 年）

Mycoplasma Testing Market Size, Share & Trends Analysis By Product, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

黴漿菌檢測市場摘要

2024年全球黴漿菌檢測市場規模估計為10.3億美元，預計2033年將達28.1億美元。

預計從 2025 年到 2033 年，該市場將以 11.94% 的複合年成長率成長。生命科學領域研發投入的增加是推動市場成長的主要因素。

製藥公司願意投入大量資源開發生物製劑和生物相似藥，而這些藥物需要嚴格的污染控制。例如，百時美施貴寶公司正在大力投資臨床實驗新藥，以支持其不斷擴大的臨床試驗計畫組合。

與其他產業相比，生物製藥及相關市場受新冠肺炎疫情的影響較小。一項發表於2022年5月的研究發現，黴漿菌檢測量與新冠肺炎相關的非藥物干預措施（NPIs）之間存在相關性。該研究分析了新冠肺炎非藥物干預措施實施後肺炎支原體的感染率。研究發現，疫情期間黴漿菌的黴漿菌下降，2020年3月至2021年3月期間全球均出現下降。這一下降主要歸因於黴漿菌傳播受到限制，導致全球黴漿菌黴漿菌感染疾病顯著減少。

隨著生物製藥和疫苗生產的擴張，生產商需要可靠的黴漿菌檢測解決方案，以確保產品的純度、安全性和合規性。因此，對先進檢測套組的需求日益成長。此外，隨著越來越多的生物製藥進入臨床開發階段，維持無污染的細胞培養變得至關重要，這也增加了對嚴格黴漿菌檢測的需求。檢測技術的持續創新有望帶來更快、更靈敏、更經濟高效的檢測方法，以滿足製藥業不斷成長的需求。

全球公共衛生措施的日益重視以及疫苗需求的成長預計將推動市場強勁成長。為支持此趨勢，各大製藥公司持續增加對生物製造基礎設施的投資。例如，默克公司於2025年10月宣布，將投資30億美元，在其位於維吉尼亞埃爾克頓的工廠建設一座佔地40萬平方英尺的製藥生產設施。這項重大投資凸顯了製藥業為擴大疫苗和生物製藥產能以滿足全球需求所做的努力。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場趨勢與展望
  • 市場動態
  • 市場限制因素分析
    • 細胞生物學研究成本高昂
    • 黴漿菌培養生長速度緩慢
  • 機會分析
  • 當前及未來市場趨勢
  • 商業環境分析
    • SWOT分析：依因素（政治/法律、經濟、技術）分類
    • 波特五力分析
  • 新冠疫情影響分析
  • Mekkochart 在黴漿菌檢測市場的產品排名
  • Mekkochart 在黴漿菌檢測市場的檢測方法

第4章：依產品進行業務分析

  • 黴漿菌檢測市場：按產品分類的波動分析
  • 裝置
  • 試劑盒和試劑
    • PCR檢測
    • 核酸檢測試劑盒
    • 染料
    • 拆卸工具包
    • 標準與控制
    • 其他
  • 服務

第5章：依技術進行業務分析

  • 黴漿菌檢測市場：依技術分類的差異分析
  • PCR
  • ELISA
  • 直接檢測法
  • 間接檢測
  • 微生物培養技術
  • 酵素法

第6章：按應用程式進行業務分析

  • 黴漿菌檢測市場：依應用領域分析波動狀況
  • 細胞株檢測
  • 病毒檢測
  • 停止細胞測試
  • 其他

第7章 依最終用途進行業務分析

  • 黴漿菌檢測市場：依最終用途分類的差異分析
  • 製藥和生物技術公司
  • 細胞庫
  • 受託研究機構
  • 學術和研究機構
  • 其他

第8章：區域商業分析

  • 2024 年及 2033 年各地區黴漿菌檢測市場佔有率
  • 北美洲
    • SWOT分析
    • 2021-2033年北美黴漿菌檢測市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • SWOT分析
    • 2021-2033年歐洲黴漿菌檢測市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太地區黴漿菌檢測市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 2021-2033年拉丁美洲黴漿菌檢測市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 2021-2033年中東及非洲黴漿菌檢測市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 主要企業市佔率分析（2024 年）
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Merck &Co., Inc.
    • Lonza Group AG
    • Charles River Laboratories International, Inc.
    • PromoCell GmbH
    • Asahi Kasei Medical Co., Ltd.
    • Sartorius AG
    • InvivoGen
    • Eurofins Scientific
    • （ATCC）American Type Culture Collection
Product Code: GVR-1-68038-897-8

Mycoplasma Testing Market Summary

The global mycoplasma testing market size was estimated at USD 1.03 billion in 2024 and is expected to reach USD 2.81 billion in 2033, growing at a CAGR of 11.94% from 2025 to 2033. The rising investments in research and development (R&D) across the life sciences sector are a significant market driver.

Pharmaceutical companies are actively channeling substantial resources into biopharmaceutical and biosimilar development, which requires stringent contamination control. For instance, Bristol-Myers Squibb has invested heavily in the production of investigational medicines to support its expanding portfolio of clinical trials.

The biopharmaceutical and related markets have not been significantly impacted by the COVID-19 pandemic when compared to other industries. According to a study published in May 2022, there is a correlation between mycoplasma testing numbers and COVID-19-related Non-Pharmaceutical Interventions (NPIs). This study analyzed the incidence of M. pneumonia after the implementation of COVID-19 NPIs. This survey showed that there has been a decrease in M. pneumoniae detection during the pandemic, and a reduction was observed globally between March 2020 and March 2021. The reduction is majorly due to restricted transmission of M. pneumonia, resulting in a significant reduction in M. pneumoniae infections across the globe.

As biopharmaceutical and vaccine production scales up, manufacturers require reliable mycoplasma testing solutions to ensure the purity, safety, and regulatory compliance of their products. Consequently, the need for advanced testing kits has intensified. Moreover, as more biologics advance through clinical development, maintaining uncontaminated cell cultures becomes critical, thereby increasing the demand for rigorous mycoplasma testing. Ongoing innovations in detection technologies are also expected to yield faster, more sensitive, and cost-effective testing methods that align with the growing requirements of the pharmaceutical industry.

The rising global emphasis on public health preparedness and the expanding demand for vaccines are expected to drive strong market growth. Supporting this trend, leading pharmaceutical companies continue to invest heavily in biomanufacturing infrastructure. For example, in October 2025, Merck & Co., Inc. announced the start of construction on a USD 3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia site. This major investment underscores the industry's commitment to expanding vaccine and biologics production capacity to meet global demand.

Global Mycoplasma Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global mycoplasma testing market report based on product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Stains
    • Elimination Kits
    • Standards & Controls
    • Others
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • Microbial Culture Techniques
  • Enzymatic Methods
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research Institutes
  • Cell Banks
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing R&D investments in life sciences
    • 3.4.2. Rising government support toward pharmaceutical and biotechnology industries
    • 3.4.3. Growing demand for biopharmaceuticals and vaccines
    • 3.4.4. Rising cell culture contamination
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of research in cell biology
    • 3.5.2. Slow rate of mycoplasma growth
  • 3.6. Opportunity Analysis
  • 3.7. Current and Future Market Trends:
  • 3.8. Business Environment Analysis
    • 3.8.1. SWOT Analysis: By Factor (Political & Legal, Economic, And Technological)
    • 3.8.2. Porter's Five Forces Analysis
  • 3.9. COVID-19 Impact Analysis
  • 3.10. Mekko Chart for Mycoplasma Testing Market, by Product
  • 3.11. Mekko Chart for Mycoplasma Testing Market, by Test Method

Chapter 4. Product Business Analysis

  • 4.1. Mycoplasma Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
    • 4.3.2. PCR Assays
      • 4.3.2.1. PCR Assays Market, 2021 - 2033 (USD Million)
    • 4.3.3. Nucleic Acid Detection Kits
      • 4.3.3.1. Nucleic Acid Detection Kits Market, 2021 - 2033 (USD Million)
    • 4.3.4. Stains
      • 4.3.4.1. Stains Market, 2021 - 2033 (USD Million)
    • 4.3.5. Elimination Kits
      • 4.3.5.1. Elimination Kits Market, 2021 - 2033 (USD Million)
    • 4.3.6. Standards & Controls
      • 4.3.6.1. Standards & Controls Market, 2021 - 2033 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2021 - 2033 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Mycoplasma Testing Market: Technology Movement Analysis
  • 5.2. PCR
    • 5.2.1. PCR Market, 2021 - 2033 (USD Million)
  • 5.3. ELISA
    • 5.3.1. ELISA Market, 2021 - 2033 (USD Million)
  • 5.4. Direct Assay
    • 5.4.1. Direct Assay Market, 2021 - 2033 (USD Million)
  • 5.5. Indirect Assay
    • 5.5.1. Indirect Assay Market, 2021 - 2033 (USD Million)
  • 5.6. Microbial Culture Techniques
    • 5.6.1. Microbial Culture Techniques Market, 2021 - 2033 (USD Million)
  • 5.7. Enzymatic Methods
    • 5.7.1. Enzymatic Methods Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Mycoplasma Testing Market: Application Movement Analysis
  • 6.2. Cell Line Testing
    • 6.2.1. Cell Line Testing Market, 2021 - 2033 (USD Million)
  • 6.3. Virus Testing
    • 6.3.1. Virus Testing Market, 2021 - 2033 (USD Million)
  • 6.4. End of Production Cells Testing
    • 6.4.1. End of Production Cells Testing Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Mycoplasma Testing Market: End Use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.3. Cell Banks
    • 7.3.1. Cell Banks Market, 2021 - 2033 (USD Million)
  • 7.4. Contract Research Organizations
    • 7.4.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mycoplasma Testing Market Share By Region, 2024 & 2033
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Mycoplasma Testing Market, 2021 - 2033 (USD MILLION)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Reimbursement Scenario
      • 8.2.5.6. Mexico Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. Japan Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. China Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. India Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Australia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Reimbursement Scenario
      • 8.4.8.6. Thailand Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Argentina Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Mycoplasma Testing Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. 10.2.1 New Product Launch
    • 9.2.2. 10.2.2 Partnerships
    • 9.2.3. 10.2.3 Acquisition
    • 9.2.4. 10.2.4 Collaboration
    • 9.2.5. 10.2.5 Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Merck & Co., Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Lonza Group AG
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Charles River Laboratories International, Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. PromoCell GmbH
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Asahi Kasei Medical Co., Ltd.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Sartorius AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. InvivoGen
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eurofins Scientific
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. (ATCC) American Type Culture Collection
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Mycoplasma Testing Market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Global Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 North America Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 Germany Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 31 Germany Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 32 Germany Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 33 Germany Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 34 UK Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 35 UK Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 36 UK Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 UK Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 France Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 41 France Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 53 Denmark Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57 Sweden Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 61 Norway Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 China Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 70 China Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Japan Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Japan Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 Japan Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 India Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 India Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 South Korea Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Australia Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Australia Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Australia Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 Thailand Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 119 UAE Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mycoplasma Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Mycoplasma Testing Market: by Product Movement Analysis
  • Fig. 16 Global Mycoplasma Testing Market, for Instruments, 2021 - 2033 (USD Million)
  • Fig. 17 Global Mycoplasma Testing Market, for Kits & Reagents, 2021 - 2033 (USD Million)
  • Fig. 18 Global Mycoplasma Testing Market, for PCR Assays, 2021 - 2033 (USD Million)
  • Fig. 19 Global Mycoplasma Testing Market, for Nucleic Acid Detection Kits, 2021 - 2033 (USD Million)
  • Fig. 20 Global Mycoplasma Testing Market, for Stains, 2021 - 2033 (USD Million)
  • Fig. 21 Global Mycoplasma Testing Market, for Elimination Kits, 2021 - 2033 (USD Million)
  • Fig. 22 Global Mycoplasma Testing Market, for Standards & Controls, 2021 - 2033 (USD Million)
  • Fig. 23 Global Mycoplasma Testing Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 24 Global Mycoplasma Testing Market, for Services, 2021 - 2033 (USD Million)
  • Fig. 25 Global Mycoplasma Testing Market: Technology Movement Analysis
  • Fig. 26 Global Mycoplasma Testing Market, for PCR, 2021 - 2033 (USD Million)
  • Fig. 27 Global Mycoplasma Testing Market, for ELISA, 2021 - 2033 (USD Million)
  • Fig. 28 Global Mycoplasma Testing Market, for Direct Assay, 2021 - 2033 (USD Million)
  • Fig. 29 Global Mycoplasma Testing Market, for Indirect Assay, 2021 - 2033 (USD Million)
  • Fig. 30 Global Mycoplasma Testing Market, for Microbial Culture Techniques, 2021 - 2033 (USD Million)
  • Fig. 31 Global Mycoplasma Testing Market, for Enzymatic Methods, 2021 - 2033 (USD Million)
  • Fig. 32 Global Mycoplasma Testing Market: Application Movement Analysis
  • Fig. 33 Global Mycoplasma Testing Market, for Cell Line Testing, 2021 - 2033 (USD Million)
  • Fig. 34 Global Mycoplasma Testing Market, for Virus Testing, 2021 - 2033 (USD Million)
  • Fig. 35 Global Mycoplasma Testing Market, for End of Production Cells Testing, 2021 - 2033 (USD Million)
  • Fig. 36 Global Mycoplasma Testing Market, for Other Applications, 2021 - 2033 (USD Million)
  • Fig. 37 Global Mycoplasma Testing Market: End use Movement Analysis
  • Fig. 38 Global Mycoplasma Testing Market, for Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD Million)
  • Fig. 39 Global Mycoplasma Testing Market, for Cell Banks, 2021 - 2033 (USD Million)
  • Fig. 40 Global Mycoplasma Testing Market, for Contract Research Organizations, 2021 - 2033 (USD Million)
  • Fig. 41 Global Mycoplasma Testing Market, for Academic & Research Institutes,
  • Fig. 42 Global Mycoplasma Testing Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways Mycoplasma Testing Market, Region 2021 - 2033 (USD Million)
  • Fig. 44 Mycoplasma Testing Market: Regional Outlook, 2024 & 2033, 2021 - 2033 (USD Million)
  • Fig. 45 North America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 47 Canada Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 49 Europe Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 50 Germany Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 51 UK Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 52 France Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 53 Italy Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 57 Norway Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 59 Japan Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 60 China Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 61 India Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 62 Australia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 68 Middle East and Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait Mycoplasma Testing Market, 2021 - 2033 (USD Million)